ClinicalTrials.Veeva

Menu

The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study

S

Simeone Andrulli, MD

Status

Completed

Conditions

Kidney Diseases

Treatments

Procedure: Native kidney biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT04948593
KidneyBiopsyRisk in Italy

Details and patient eligibility

About

The estimates risks and benefits of the percutaneous kidney biopsy have been reported mainly from retrospective studies. So far no prospective multicentre studies has been designed to identify rates of biopsy related complications. The aim of this prospective multicentre study was to evaluate safety and complication events related to biopsies on native kidney in Italy.

Full description

Kidney biopsies performed in 54 italian nephrology centres from 2012 to 2020 were included.

Primary outcome of the study was any major complication, such as haemoglobin decrease more than 2 g/dL, macroematuria, gross ematoma, blood transfusion, artero-venous fistula, invasive intervention, pain, symptomatic hypotension, and/or rapid serum creatinine increase.

Centre and individual patient risk predictors were analysed using multivariate logistic regression analysis.

Enrollment

5,304 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult or pediatric patients with a kidney disease
  • informed Consent

Exclusion criteria

  • patient with a transplanted kidney

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems